NASDAQ:DNAY
Codex DNA, Inc.
- Stock
Last Close
1.20
04/01 05:00
Market Cap
38.32M
Beta: -
Volume Today
19.95K
Avg: 79.40K
PE Ratio
−0.83
PFCF: −0.79
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|
average inventory | 1.48M - | 2.28M 53.86% | ||
average payables | 1.84M - | 1.90M 2.82% | ||
average receivables | 2.58M - | 4.76M 84.53% | ||
book value per share | -1.19 - | 4.26 456.59% | 1.58 62.89% | |
capex per share | -0.01 - | -0.09 808.82% | -0.15 74.36% | |
capex to depreciation | -0.14 - | -2.04 1,358.32% | -2.67 30.95% | |
capex to operating cash flow | 0.01 - | 0.05 280.91% | 0.12 128.44% | |
capex to revenue | -0.03 - | -0.17 441.20% | -0.16 3.00% | |
cash per share | 0.63 - | 3.88 515.06% | 1.48 61.92% | |
days of inventory on hand | 74.34 - | 128.16 72.41% | 67.82 47.08% | |
days payables outstanding | 147.31 - | 135.25 8.19% | 39.92 70.48% | |
days sales outstanding | 82.81 - | 121.14 46.28% | 77.84 35.74% | |
debt to assets | 1.95 - | 0.22 88.75% | 0.26 20.19% | |
debt to equity | -2.06 - | 0.28 113.65% | 0.46 64.00% | |
dividend yield | ||||
earnings yield | -0.05 - | -0.17 270.54% | -1.37 709.35% | |
enterprise value | 389.22M - | 153.71M 60.51% | 26.36M 82.85% | |
enterprise value over ebitda | -24.54 - | -3.90 84.11% | -0.57 85.46% | |
ev to operating cash flow | -25.31 - | -4.19 83.45% | -0.68 83.74% | |
ev to sales | 59.19 - | 13.92 76.48% | 0.96 93.10% | |
free cash flow per share | -0.73 - | -1.81 147.37% | -1.47 18.96% | |
free cash flow yield | -0.04 - | -0.17 323.73% | -1.22 629.36% | |
graham net net | -1.76 - | 2.87 263.64% | 0.48 83.15% | |
graham number | 4.76 - | 13.23 177.73% | 7.64 42.23% | |
income quality | 0.85 - | 0.94 10.30% | 0.80 15.21% | |
intangibles to total assets | 0.22 - | 0.14 33.61% | 0.21 43.24% | |
interest coverage | -23.71 - | 25.84 208.97% | 40.85 58.08% | |
interest debt per share | 0.42 - | 0.23 45.35% | 0.69 196.77% | |
inventory turnover | 4.91 - | 2.85 42.00% | 5.38 88.97% | |
invested capital | -0.33 - | 0.07 121.21% | 0.46 563.51% | |
market cap | 394.36M - | 230.22M 41.62% | 35.36M 84.64% | |
net current asset value | -35.14M - | 67.71M 292.68% | 20.30M 70.03% | |
net debt to ebitda | 0.32 - | 1.94 499.38% | 0.19 90.04% | |
net income per share | -0.84 - | -1.83 116.31% | -1.64 10.07% | |
operating cash flow per share | -0.72 - | -1.72 138.59% | -1.31 23.67% | |
payables turnover | 2.48 - | 2.70 8.92% | 9.14 238.79% | |
receivables turnover | 4.41 - | 3.01 31.64% | 4.69 55.62% | |
research and ddevelopement to revenue | 1.36 - | 1.32 2.93% | 0.86 35.09% | |
return on tangible assets | -0.86 - | -0.39 54.27% | -0.75 91.52% | |
revenue per share | 0.31 - | 0.52 67.93% | 0.93 79.74% | |
roe | 0.71 - | -0.43 160.66% | -1.04 142.33% | |
roic | 13.05 - | 0.68 94.77% | -0.71 204.36% | |
sales general and administrative to revenue | 0.63 - | 1.29 105.16% | 0.81 37.40% | |
shareholders equity per share | -1.19 - | 4.26 456.59% | 1.58 62.89% | |
stock based compensation to revenue | 0.01 - | 0.10 1,403.96% | 0.14 38.14% | |
tangible asset value | -31.28M - | 74.06M 336.75% | 29.80M 59.76% | |
tangible book value per share | -1.47 - | 3.47 336.75% | 1.01 70.89% | |
working capital | 11.56M - | 83.45M 622.14% | 41.59M 50.16% |
All numbers in USD (except ratios and percentages)